Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Niesor

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Opinion in Lipidology|May 19, 2011
Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolismEric J Niesor
Biology|January 9, 2015
Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?Eric J Niesor
Archives of Medical Research|May 27, 2015
Potential Signal Transduction Regulation by HDL of the β2-Adrenergic Receptor Pathway. Implications in Selected Pathological SituationsEric J Niesor, Renée Benghozi
Cardiovascular Drugs and Therapy|December 2, 2015
Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell DiseaseEric J Niesor, Renée Benghozi, Philippe Amouyel, et al.
Atherosclerosis|October 11, 2011
Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjectsEric J Niesor, Evelyne Chaput, Andreas Staempfli, et al.
Biochimica Et Biophysica Acta|July 23, 2013
Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETPCyrille Maugeais, Anne Perez, Elisabeth von der Mark, et al.
American Heart Journal|March 20, 2012
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging studyChristie M Ballantyne, Michael Miller, Eric J Niesor, et al.
Membranes|November 24, 2022
Red Blood Cell Membrane Cholesterol May Be a Key Regulator of Sickle Cell Disease Microvascular ComplicationsEric J Niesor, Elie Nader, Anne Perez, et al.
Lipids|October 11, 2014
Effect of compounds affecting ABCA1 expression and CETP activity on the HDL pathway involved in intestinal absorption of lutein and zeaxanthinEric J Niesor, Evelyne Chaput, Jean-Luc Mary, et al.
Lipids|October 5, 2014
Treatment of low HDL-C subjects with the CETP modulator dalcetrapib increases plasma campesterol only in those without ABCA1 and/or ApoA1 mutationsEric J Niesor, David Kallend, Darren Bentley, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Lipidology|May 19, 2011
Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolismEric J Niesor
Biology|January 9, 2015
Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?Eric J Niesor
Archives of Medical Research|May 27, 2015
Potential Signal Transduction Regulation by HDL of the β2-Adrenergic Receptor Pathway. Implications in Selected Pathological SituationsEric J Niesor, Renée Benghozi
Cardiovascular Drugs and Therapy|December 2, 2015
Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell DiseaseEric J Niesor, Renée Benghozi, Philippe Amouyel, et al.
Atherosclerosis|October 11, 2011
Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjectsEric J Niesor, Evelyne Chaput, Andreas Staempfli, et al.
Biochimica Et Biophysica Acta|July 23, 2013
Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETPCyrille Maugeais, Anne Perez, Elisabeth von der Mark, et al.
American Heart Journal|March 20, 2012
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging studyChristie M Ballantyne, Michael Miller, Eric J Niesor, et al.
Membranes|November 24, 2022
Red Blood Cell Membrane Cholesterol May Be a Key Regulator of Sickle Cell Disease Microvascular ComplicationsEric J Niesor, Elie Nader, Anne Perez, et al.
Lipids|October 11, 2014
Effect of compounds affecting ABCA1 expression and CETP activity on the HDL pathway involved in intestinal absorption of lutein and zeaxanthinEric J Niesor, Evelyne Chaput, Jean-Luc Mary, et al.
Lipids|October 5, 2014
Treatment of low HDL-C subjects with the CETP modulator dalcetrapib increases plasma campesterol only in those without ABCA1 and/or ApoA1 mutationsEric J Niesor, David Kallend, Darren Bentley, et al.
Pageof 3